Background/Aims: The polyamine oxidase inhibitor MDL-72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine) were expected to increase the abundance of spermine, a powerful inhibitor of platelet activation. Nothing is known, however, on the sensitivity of platelet function and survival to MDL-72527 exposure. The present study thus explored whether MDL-72527 modifies function and survival of platelets without and with platelet activation by collagen related peptide (CRP). Methods: Platelets isolated from wild-type mice were exposed for 30 minutes to MDL-72527 (100 µM) with or without subsequent activation with CRP (2-5 µg/ml). Flow cytometry was employed to estimate cytosolic Ca 2+ -activity ([Ca 2+ ] i ) from Fluo-3 fluorescence, platelet degranulation from P-selectin abundance, integrin activation from α IIb β 3 integrin abundance, generation of reactive oxygen species (ROS) from DCFDA fluorescence, phospholipid scrambling of the cell membrane from annexin-V-binding, platelet volume from forward scatter and aggregation utilizing staining with CD9-APC and CD9-PE. Results: In the absence of CRP, exposure of platelets to MDL-72527 did not significantly modify [Ca 2+ ] i , P-selectin abundance, α IIb β 3 integrin abundance, ROS, annexin-Vbinding, and forward scatter. The addition of 2-5 µg/ml CRP was followed by significant increase of [Ca 2+
Introduction
N1,N4-bis(2,3-butadienyl)-1,4-butanediamine (MDL-72527), a lysosomotropic compound, is a strong inhibitor of spermine degrading polyamine oxidase [1] [2] [3] . Spermine is a powerful inhibitor of platelet aggregation [4] [5] [6] [7] , which contributes to primary hemostasis following vascular injury, to acute thrombotic occlusion following atherosclerotic plaque rupture [8, 9] , and to arterial thrombosis, vascular inflammation and atherogenesis [8, 10] . Platelet activation involves increase of cytosolic Ca 2+ concentration ([Ca 2+ ] i ) [11] , resulting from Ca 2+ release from intracellular stores [12] and subsequent opening of the Ca 2+ releaseactivated channel (CRAC) Orai1 (CRACM1) [11, [13] [14] [15] [16] .
To the best of our knowledge, nothing is known about an effect of MDL-72527 on platelet function. The present study thus explored whether MDL-72527 modifies the effect of collagen related peptide on Ca 2+ entry, activation, and apoptosis of blood platelets.
Materials and Methods

Mice
All animal experiments were conducted according to the German law for the welfare of animals and were approved by the authorities of the state of Baden-Württemberg (Regierungspräsidium). Experiments were performed with blood platelets isolated from wild type mice. The mice had free access to water and control chow (Ssniff, Soest, Germany).
Preparation of mouse platelets
Platelets were obtained from 10-to 12-week-old mice of either sex. The mice were anesthetized and 800 µl blood was drawn from the retro-orbital plexus into tubes with 200 µl acid-citrate-dextrose buffer before the mice were sacrificed [17] . Platelet rich plasma (PRP) was obtained by centrifugation at 260 g for 5 minutes. Afterwards PRP was centrifuged at 640 g for 5 minutes to pellet the platelets. Where necessary apyrase (0.02 U/ml; Sigma-Aldrich) and prostaglandin I 2 (0.5 µM; Calbiochem) were added to the PRP to prevent activation of platelets during isolation. After two washing steps the pellet of washed platelets was re-suspended in modified Tyrode-HEPES buffer (pH 7.4, supplemented with 1 mM CaCl 2 ). Where indicated, CRP (kindly provided by R. Farndale, University of Cambridge, Cambridge, UK) was added.
Cytosolic calcium
For the measurement of the cytosolic Ca 2+ concentration the platelet preparation was washed once in Tyrode buffer (pH 7.4), stained with 3 µM Fluo-3AM (Biotinium, USA) in the same buffer and incubated at 37°C for 30 minutes. Following the indicated experimental treatment, relative fluorescence was measured utilizing a BD FACS Calibur (BD Biosciences, Heidelberg, Germany) [18] .
P-selectin and activated integrin abundance
Fluorophore-labeled antibodies were utilized for the detection of P-selectin expression (Wug.E9-FITC) and the active form of α IIb β 3 integrin (JON/A-PE). Washed mouse platelets (1x10 6 ) were suspended in modified Tyrode buffer (pH 7.4) containing 1 mM CaCl 2 and antibodies (1:10 dilution) and subsequently subjected to the respective treatments and for the indicated time periods at room temperature (RT). The reaction was stopped by addition of PBS and the samples were immediately analyzed on a BD FACS Calibur.
Reactive oxygen species
The abundance of reactive oxygen species (ROS) was determined utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA). To load the platelets, DCFDA (Sigma, Schnelldorf, Germany) was added to the cell suspension at a final concentration of 10 µM. Following the indicated experimental treatments, fluorescence was measured by flow cytometry utilizing a BD FACS Calibur (BD Biosciences, Heidelberg, Germany).
Phosphatidylserine exposure and forward scatter
Phosphatidylserine exposure was determined in platelets with and without 10 minutes CRP treatment. To this end, the platelet preparation was centrifuged at 660 g for 5 minutes followed by washing once with Tyrode buffer (pH 7. 
Platelet aggregation
Aggregation was determined utilizing flow cytometry as previously described [19] . To this end platelets were labeled with CD9-APC and CD9-PE monoclonal antibodies (1:100 dilution, Abcam) for 15 minutes at room temperature. Following incubation, differently labeled samples were washed twice, mixed 1:1, and incubated in 100 µM MDL-72527 (Sigma, Germany) for 30 min at 37 o C. Pre-incubated platelets were activated with 2 µg/ml collagen related peptide at 37 o C while shaking at 1000 rpm. The samples were measured utilizing a BD FACS Calibur (BD Biosciences, Heidelberg, Germany). For quantification, a quadrant was set in the dot plot of respective channels on non-stimulated platelets. The appearance of double-colored events in the upper right quadrant (Q2) was quantified as percentage of total amount of labeled events (Q1+Q2+Q4) at every time point analyzed.
Statistical analysis
Data are provided as means ± SEM; n represents the number of independent experiments. All data were tested for significance using ANOVA with Tukey's test as post-test or unpaired student's t-test as appropriate. Results with p<0.05 were considered statistically significant.
Results
The present study explored whether polyamine oxidase inhibitor N1,N4-bis(2,3-butadienyl)-1,4-butanediamine (MDL-72527) modifies platelet function in the absence and presence of platelet activator collagen related peptide (CRP). To this end, murine platelets were isolated from wild type mice and exposed for 30 min to 100 µM MDL-72527 without and with CRP treatment (2-5 µg/ml). ] i , an effect significantly blunted in the presence of 100 µM MDL-72527 ( Fig. 1B and C) .
P-selectin abundance on the platelet surface, taken as measure of platelet degranulation, was determined by flow cytometry utilizing specific antibodies. As illustrated in Fig. 2A and C, the P-selectin abundance was negligible at the surface of resting platelets and not significantly modified by MDL-72527 treatment. CRP (2 µg/ml) treatment was followed by a sharp increase of P-selectin abundance, an effect significantly blunted in the presence of 100 µM MDL-72527 ( Fig. 2B and C) . The abundance of active integrin α IIb β 3 , another indicator of platelet activation, was again determined by flow cytometry utilizing specific antibodies. As shown in Fig. 2D and F, the abundance of active integrin α IIb β 3 was again negligible at the surface of resting platelets, but was significantly increased by treatment with CRP (2 µg/ml). Again, the effect of CRP on the abundance of active integrin α IIb β 3 was significantly blunted in the presence of 100 µM MDL-72527 ( Fig. 2E and F) .
The abundance of reactive oxygen species (ROS) was quantified utilizing DCFDA fluorescence. As shown in Fig. 3A and C, the ROS abundance was low in resting platelets. Following a 2 µg/ml CRP treatment, ROS generation was significantly increased, an effect significantly blunted in the presence of MDL-72527 treatment (Fig. 3B and C) .
Annexin-V-binding was taken as evidence for cell membrane scrambling with phosphatidylserine translocation to the platelet surface. As illustrated in Fig. 4A and C, the percentage of annexin-V positive platelets was again negligible in untreated platelets, irrespective of the presence of MDL-72527. CRP (5 µg/ml) within 10 min significantly enhanced the percentage of annexin-V binding platelets, an effect again significantly blunted in the presence of 100 µM MDL-72527 ( Fig. 4B and C) .
Forward scatter determined by flow cytometry was taken as a measure of platelet volume. As illustrated in Fig. 4D and F, prior to stimulation with CRP, forward scatter was similar in the absence and presence of MDL-72527. CRP (5 µg/ml) treatment within 10 min was followed by 
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Cellular Physiology and Biochemistry a significant decrease of forward scatter in the absence, but not in the presence of 100 µM MDL-72527 ( Fig. 4E and F) . In order to quantify platelet aggregation, platelets were labeled with two distinct dyes and the coincidence of the two dyes estimated by flow cytometry. As illustrated in Fig. 5 , aggregation of resting platelets was similarly low in MDL-72527 treated and untreated platelets. CRP (2 µg/ml) treatment within a few min significantly increased the platelet aggregation, an effect significantly blunted by MDL-72527 treatment.
Discussion
The present observations uncover a novel effect of the polyamine oxidase inhibitor MDL-72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine), i.e. suppression of platelet activation and apoptosis following treatment with collagen related peptide (CRP). In the absence of CRP, MDL-72527 did not appreciably modify the tested platelet properties. In contrast, MDL-72527 significantly blunted or even virtually abrogated the effect of CRP on platelet cytosolic Ca 2+ concentration ([Ca   2+ ] i ), degranulation, integrin activation, oxidative stress, cell membrane scrambling, cell shrinkage, and aggregation. Accordingly, MDL-72527 attenuates the procoagulant function of platelets, which is instrumental for hemostasis [20] .
In theory, the effects of MDL-72527 could be explained by inhibition of polyamine oxidase which could be expected to enhance the abundance of spermine, a powerful inhibitor of platelet aggregation [4] [5] [6] [7] . The present observations do, however, not rule out that MDL-72527 modifies platelet activation and survival through mechanisms other than decreased spermine degradation.
Signaling leading to platelet activation and apoptosis as well as and thrombus formation involves increase of [Ca 2+ ] i [14, 21] and the negative effects of MDL-72527 on activation and cell membrane scrambling could have been secondary to its effect on [Ca 2+ ] i . The increase ] i fosters the development of arterial thrombosis [11] .
Increased [Ca
2+
] i further triggers platelet apoptosis characterized by phospholipid scrambling of the cell membrane with translocation of phosphatidylserine to the platelet surface [10, [22] [23] [24] . The inhibition of CRP-induced Ca 2+ entry may thus contribute or even account for the inhibition of CRP-induced phosphatidylserine exposure in the presence of MDL-72527. Phosphatidylserine exposure at the platelet surface triggers the formation of thrombin, which potentiates platelet activation [22] [23] [24] [25] . Phosphatidylserine exposure mediates the binding of platelets to macrophages with subsequent platelet phagocytosis [26] . Platelet activation and phosphatidylserine exposure stimulate platelet aggregation, which was again slightly, but significantly blunted by MDL-72527.
In conclusion, polyamine oxidase inhibitor MDL-72527 is a powerful inhibitor of CRPinduced increase [Ca 2+ ] i , oxidative stress, degranulation, integrin activation, cell membrane scrambling, shrinkage, and aggregation in and of platelets, thus suppressing platelet activation and apoptosis. 
